Anika Therapeutics Announces New CFO and Executive Changes

Anika Therapeutics (ANIK) has issued an announcement.

Anika Therapeutics, Inc. has appointed Stephen Griffin as the new Executive Vice President, Chief Financial Officer, and Treasurer starting June 3, 2024. He replaces Michael Levitz, who resigned but will remain in an advisory capacity until the end of the year. Griffin’s attractive compensation package includes a $500,000 base salary, potential for a 60% bonus, and $2,000,000 in equity awards, along with severance protections. Levitz will retain his salary and receive a $100,000 parting payment while upholding a confidentiality agreement.

For a thorough assessment of ANIK stock, go to TipRanks’ Stock Analysis page.